These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effective Decrease in Myopia Progression With Two Mechanisms of Management. Erdinest N, Atar-Vardi M, Lavy I, London N, Landau D, Pras E, Morad Y. J Pediatr Ophthalmol Strabismus; 2024; 61(3):204-210. PubMed ID: 38112389 [Abstract] [Full Text] [Related]
3. Low-Concentration Atropine Monotherapy vs. Combined with MiSight 1 Day Contact Lenses for Myopia Management. Erdinest N, London N, Lavy I, Landau D, Ben Ephraim Noyman D, Levinger N, Morad Y. Vision (Basel); 2022 Dec 12; 6(4):. PubMed ID: 36548935 [Abstract] [Full Text] [Related]
4. Interventions to slow progression of myopia in children. Walline JJ, Lindsley KB, Vedula SS, Cotter SA, Mutti DO, Ng SM, Twelker JD. Cochrane Database Syst Rev; 2020 Jan 13; 1(1):CD004916. PubMed ID: 31930781 [Abstract] [Full Text] [Related]
6. Management of progressive school myopia with topical atropine eyedrops and photochromic bifocal spectacles. Romano PE, Donovan JP. Binocul Vis Strabismus Q; 2000 Jan 13; 15(3):257-60. PubMed ID: 10960233 [Abstract] [Full Text] [Related]
7. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. Fu A, Stapleton F, Wei L, Wang W, Zhao B, Watt K, Ji N, Lyu Y. Br J Ophthalmol; 2020 Nov 13; 104(11):1535-1541. PubMed ID: 32086237 [Abstract] [Full Text] [Related]
8. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kakehashi A. Jpn J Ophthalmol; 2018 Sep 13; 62(5):544-553. PubMed ID: 29974278 [Abstract] [Full Text] [Related]
9. Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis. Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, Saw SM, Chen H, Bao F, Zhao Y, Hu L, Li X, Gao R, Lu W, Du Y, Jinag Z, Yu A, Lian H, Jiang Q, Yu Y, Qu J. Ophthalmology; 2016 Apr 13; 123(4):697-708. PubMed ID: 26826749 [Abstract] [Full Text] [Related]
10. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes. Kothari M, Rathod V. Indian J Ophthalmol; 2017 Nov 13; 65(11):1178-1181. PubMed ID: 29133646 [Abstract] [Full Text] [Related]
17. Treatment of progressive myopia with 0.01% Atropine in children and adolescents: an Italian 4-year follow-up study. Di Meglio M, Giunta P, Rechichi M, Trofa A, Galantuomo G, Galantuomo N, Palmieri S, Pacente L, Salducci M. Clin Ter; 2024 Nov 13; 175(5):265-270. PubMed ID: 39400089 [Abstract] [Full Text] [Related]
18. Rebound Effect in the Misight Assessment Study Spain (Mass). Ruiz-Pomeda A, Prieto-Garrido FL, Hernández Verdejo JL, Villa-Collar C. Curr Eye Res; 2021 Aug 13; 46(8):1223-1226. PubMed ID: 33460537 [Abstract] [Full Text] [Related]
19. Efficacy and safety of 0.01% atropine combined with orthokeratology lens in delaying juvenile myopia: An observational study. Guo Y, Liu Y, Hu Z, Li Y, Zhang H, Zhao S. Medicine (Baltimore); 2024 Jun 14; 103(24):e38384. PubMed ID: 38875374 [Abstract] [Full Text] [Related]